Moreover, the exploration of various molecular targets, such as EGFR, EGFRvIII, miRNAs, MET, and other signaling pathways, underscores the complex nature of glioma and the potential for targeted therapies. The gene discussed is EGFR; the disease is central nervous system cancer.